| 1 |
Cheng F, Huang Z, Wei W, Li Z. Efficacy and safety of mesenchymal stem cells in the treatment of perianal fistulas in Crohn's disease: a meta-analysis of randomized controlled trials. Rev Esp Enferm Dig 2023. [PMID: 36896932 DOI: 10.17235/reed.2023.9213/2022] [Reference Citation Analysis]
|
| 2 |
Czerwiec K, Zawrzykraj M, Deptuła M, Skoniecka A, Tymińska A, Zieliński J, Kosiński A, Pikuła M. Adipose-Derived Mesenchymal Stromal Cells in Basic Research and Clinical Applications. Int J Mol Sci 2023;24. [PMID: 36835295 DOI: 10.3390/ijms24043888] [Reference Citation Analysis]
|
| 3 |
Zhou Z, Ouboter LF, Peeters KCMJ, Hawinkels LJAC, Holman F, Pascutti MF, Barnhoorn MC, van der Meulen-de Jong AE. Crohn's Disease-Associated and Cryptoglandular Fistulas: Differences and Similarities. J Clin Med 2023;12. [PMID: 36675403 DOI: 10.3390/jcm12020466] [Reference Citation Analysis]
|
| 4 |
Rizzo G, Rubbino F, Elangovan S, Sammarco G, Lovisa S, Restelli S, Pineda Chavez SE, Massimino L, Lamparelli L, Paulis M, Maroli A, Roda G, Shalaby M, Carvello M, Foppa C, Drummond SP, Spaggiari P, Ungaro F, Spinelli A, Malesci A, Repici A, Day AJ, Armuzzi A, Danese S, Vetrano S. Dysfunctional Extracellular Matrix Remodeling Supports Perianal Fistulizing Crohn's Disease by a Mechanoregulated Activation of the Epithelial-to-Mesenchymal Transition. Cell Mol Gastroenterol Hepatol 2023;15:741-64. [PMID: 36521659 DOI: 10.1016/j.jcmgh.2022.12.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Fernandes SR, Serrazina J, Botto IA, Leal T, Guimarães A, Garcia JL, Rosa I, Prata R, Carvalho D, Neves J, Campelo P, Ventura S, Silva A, Coelho M, Sequeira C, Oliveira AP, Portela F, Ministro P, Tavares de Sousa H, Ramos J, Claro I, Gonçalves R, Correia LA, Marinho RT, Cortez-Pinto H, Magro F. Transmural remission improves clinical outcomes up to 5 years in Crohn's disease. United European Gastroenterol J 2023;11:51-9. [PMID: 36575615 DOI: 10.1002/ueg2.12356] [Reference Citation Analysis]
|
| 6 |
Cooper J, Joseph C, Zagrodzky J, Woods C, Metzl M, Turer RW, McDonald SA, Kulstad E, Daniels J. Active esophageal cooling during radiofrequency ablation of the left atrium: data review and update. Expert Rev Med Devices 2022;19:949-57. [PMID: 36413154 DOI: 10.1080/17434440.2022.2150930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Biener-ramanujan E, Rosier F, Coetzee SG, Mcgovern DDP, Hazelett D, Targan SR, Gonsky R. Diagnostic and therapeutic potential of RNASET2 in Crohn’s disease: Disease-risk polymorphism modulates allelic-imbalance in expression and circulating protein levels and recombinant-RNASET2 attenuates pro-inflammatory cytokine secretion. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.999155] [Reference Citation Analysis]
|
| 8 |
McGregor CGC, Tandon R, Simmons A. Pathogenesis of Fistulating Crohn's Disease: A Review. Cell Mol Gastroenterol Hepatol 2023;15:1-11. [PMID: 36184031 DOI: 10.1016/j.jcmgh.2022.09.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Cote LE, Feldman JL. Won’t You be My Neighbor: How Epithelial Cells Connect Together to Build Global Tissue Polarity. Front Cell Dev Biol 2022;10:887107. [DOI: 10.3389/fcell.2022.887107] [Reference Citation Analysis]
|
| 10 |
Aboubakr A, Gottlieb ZS, Riggs AR, Johnson SO, Jimenez D, Rekawek P, Mella MT, Dubinsky MC. Peripartum Exposure to Biologic Therapy Does Not Impact Postpartum Wound Healing in Women With IBD. Inflamm Bowel Dis 2022;28:843-9. [PMID: 34272560 DOI: 10.1093/ibd/izab165] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Garcia-Olmo D, Gilaberte I, Binek M, D Hoore AJL, Lindner D, Selvaggi F, Spinelli A, Panés J. Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial. Dis Colon Rectum 2022;65:713-20. [PMID: 34890373 DOI: 10.1097/DCR.0000000000002325] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 12 |
Chandrasinghe P. Surgical Management of Small Bowel Crohn's Disease. Front Surg 2022;9:759668. [DOI: 10.3389/fsurg.2022.759668] [Reference Citation Analysis]
|
| 13 |
Kozera EK, Frew JW. The pathogenesis of hidradenitis suppurativa: Evolving paradigms in a complex disease. Dermatological Reviews 2022;3:39-49. [DOI: 10.1002/der2.113] [Reference Citation Analysis]
|
| 14 |
Nazari H, Naei VY, Tabasi AH, Badripour A, Akbari Asbagh R, Keramati MR, Sharifi A, Behboudi B, Kazemeini A, Abbasi M, Keshvari A, Ahmadi Tafti SM. Advanced Regenerative Medicine Strategies for Treatment of Perianal Fistula in Crohn's Disease. Inflamm Bowel Dis 2022;28:133-42. [PMID: 34291798 DOI: 10.1093/ibd/izab151] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 15 |
Hon H, Ho P, Lee J, Mahmud NAA, Munir HB, Ramasamy TS, Govindasamy V, Then K, Das AK, Cheong S. An Affordable Approach of Mesenchymal Stem Cell Therapy in Treating Perianal Fistula Treatment. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/5584_2022_716] [Reference Citation Analysis]
|
| 16 |
Frew JW. Follicular Occlusion and Inflammation. A Comprehensive Guide to Hidradenitis Suppurativa 2022. [DOI: 10.1016/b978-0-323-77724-7.00010-3] [Reference Citation Analysis]
|
| 17 |
Sebbagh AC, Rosenbaum B, Péré G, Alric H, Berger A, Wilhelm C, Gazeau F, Mathieu N, Rahmi G, Silva AKA. Regenerative medicine for digestive fistulae therapy: Benefits, challenges and promises of stem/stromal cells and emergent perspectives via their extracellular vesicles. Adv Drug Deliv Rev 2021;179:113841. [PMID: 34175308 DOI: 10.1016/j.addr.2021.113841] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 18 |
Mamie C, Bruckner RS, Lang S, Shpigel NY, Turina M, Rickenbacher A, Cabalzar-Wondberg D, Chvatchko Y, Rogler G, Scharl M. MMP9 expression in intestinal fistula from patients with fistulizing CD and from human xenograft mouse model. Tissue Barriers 2021;:1994350. [PMID: 34709129 DOI: 10.1080/21688370.2021.1994350] [Reference Citation Analysis]
|
| 19 |
Porwal A, Kundu GC, Bhagwat G, Butti R. Polyherbal formulation Anoac‑H suppresses the expression of RANTES and VEGF for the management of bleeding hemorrhoids and fistula. Mol Med Rep 2021;24:736. [PMID: 34414451 DOI: 10.3892/mmr.2021.12376] [Reference Citation Analysis]
|
| 20 |
Lu S, Zhu K, Guo Y, Wang E, Huang J. Evaluation of animal models of Crohn's disease with anal fistula (Review). Exp Ther Med 2021;22:974. [PMID: 34335916 DOI: 10.3892/etm.2021.10406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 21 |
Gu B, De Gregorio M, Pipicella JL, Vande Casteele N, Andrews JM, Begun J, Connell W, D'Souza B, Gholamrezaei A, Hart A, Liew D, Radford-Smith G, Rimola J, Sutherland T, Toong C, Woods R, Wu Y, Xuan W, Williams AJ, Ng W, Ding NS, Connor S. Prospective randomised controlled trial of adults with perianal fistulising Crohn's disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol. BMJ Open 2021;11:e043921. [PMID: 34210720 DOI: 10.1136/bmjopen-2020-043921] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 22 |
Schwandner O. Stem cell injection for complex anal fistula in Crohn’s disease: A single-center experience. World J Gastroenterol 2021; 27(24): 3643-3653 [PMID: 34239275 DOI: 10.3748/wjg.v27.i24.3643] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 23 |
Włodarczyk M, Włodarczyk J, Sobolewska-Włodarczyk A, Trzciński R, Dziki Ł, Fichna J. Current concepts in the pathogenesis of cryptoglandular perianal fistula. J Int Med Res 2021;49:300060520986669. [PMID: 33595349 DOI: 10.1177/0300060520986669] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 24 |
Couper C, Doriot A, Siddiqui MTR, Steiger E. Nutrition Management of the High-Output Fistulae. Nutr Clin Pract 2021;36:282-96. [PMID: 33368576 DOI: 10.1002/ncp.10608] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 25 |
Cabalzar-wondberg D, Turina M. Mesenchymale Stammzellen als neue Therapie bei Morbus-Crohn-Patienten mit Fisteln. Schweiz Gastroenterol 2020;1:130-137. [DOI: 10.1007/s43472-020-00026-8] [Reference Citation Analysis]
|
| 26 |
de la Portilla F, Jiménez-Salido A, Araujo-Miguez A, Maestre-Sanchez MV, Reyes-Diaz ML, Ramallo-Solís I, Ramos-Fernández M, Vázquez-Monchul JM, García-Cabrera AM, Jimenez-Rodríguez RM, Díaz-Pavón JM, Padillo-Ruiz FJ. Autologous Platelet-Rich Plasma in the Treatment of Perianal Fistula in Crohn's Disease. J Gastrointest Surg 2020;24:2814-21. [PMID: 31823319 DOI: 10.1007/s11605-019-04480-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 27 |
Lightner AL, Ashburn JH, Brar MS, Carvello M, Chandrasinghe P, van Overstraeten ADB, Fleshner PR, Gallo G, Kotze PG, Holubar SD, Reza LM, Spinelli A, Strong SA, Tozer PJ, Truong A, Warusavitarne J, Yamamoto T, Zaghiyan K. Fistulizing Crohn's disease. Current Problems in Surgery 2020;57:100808. [DOI: 10.1016/j.cpsurg.2020.100808] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 28 |
Nadpara N, Reichenbach ZW, Ehrlich AC, Friedenberg F. Current Status of Medical Therapy for Inflammatory Bowel Disease: The Wealth of Medications. Dig Dis Sci 2020;65:2769-79. [PMID: 32661765 DOI: 10.1007/s10620-020-06471-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 29 |
Reginelli A, Vacca G, Giovine S, Izzo A, Agostini A, Belfiore MP, Cellina M, Floridi C, Borgheresi A, Palumbo P, Giovagnoni A, Cappabianca S, Grassi R. MRI of perianal fistulas in Crohn's disease. Acta Biomed 2020;91:27-33. [PMID: 32945276 DOI: 10.23750/abm.v91i8-S.9970] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
|
| 30 |
Kim HS, In SK, Kim BS, Park JH, Yi HS, Kim HI, Kim YS, Kim HY. Chronic Ulcer on Flank Region as First Manifestation of Crohn’s Disease. J Wound Manag Res 2020;16:117-120. [DOI: 10.22467/jwmr.2020.01074] [Reference Citation Analysis]
|
| 31 |
Frew JW. Hidradenitis suppurativa is an autoinflammatory keratinization disease: A review of the clinical, histologic, and molecular evidence. JAAD Int 2020;1:62-72. [PMID: 34409324 DOI: 10.1016/j.jdin.2020.05.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 32 |
Ortiz-Masiá D, Gisbert-Ferrándiz L, Bauset C, Coll S, Mamie C, Scharl M, Esplugues JV, Alós R, Navarro F, Cosín-Roger J, Barrachina MD, Calatayud S. Succinate Activates EMT in Intestinal Epithelial Cells through SUCNR1: A Novel Protagonist in Fistula Development. Cells 2020;9:E1104. [PMID: 32365557 DOI: 10.3390/cells9051104] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 33 |
Assaraf J, Lambrescak E, Lefèvre JH, de Parades V, Bourguignon J, Etienney I, Taouk M, Atienza P, Zeitoun JD. Increased Long-term Risk of Anal Fistula After Proctologic Surgery: A Case-Control Study. Ann Coloproctol 2021;37:90-3. [PMID: 32054251 DOI: 10.3393/ac.2019.06.18] [Reference Citation Analysis]
|
| 34 |
Schlussel AT, Alavi K. Anal Conditions: Anorectal Crohn’s Disease—Fistula. Clinical Decision Making in Colorectal Surgery 2020. [DOI: 10.1007/978-3-319-65942-8_15] [Reference Citation Analysis]
|
| 35 |
García-Olmo D, Van Assche G, Tagarro I, Diez MC, Richard MP, Khalid JM, van Dijk M, Bennett D, Hokkanen SRK, Panés J. Prevalence of Anal Fistulas in Europe: Systematic Literature Reviews and Population-Based Database Analysis. Adv Ther 2019;36:3503-18. [PMID: 31656013 DOI: 10.1007/s12325-019-01117-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 36 |
Gao D, Medina MG, Alameer E, Nitz J, Tsoraides S. A case report on delayed diagnosis of perforated Crohn's disease with recurrent intra-psoas abscess requiring omental patch. Int J Surg Case Rep 2019;65:325-8. [PMID: 31770708 DOI: 10.1016/j.ijscr.2019.11.021] [Reference Citation Analysis]
|
| 37 |
Haddow JB, Musbahi O, MacDonald TT, Knowles CH. Comparison of cytokine and phosphoprotein profiles in idiopathic and Crohn’s disease-related perianal fistula. World J Gastrointest Pathophysiol 2019; 10(4): 42-53 [PMID: 31750007 DOI: 10.4291/wjgp.v10.i4.42] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 38 |
Schwartz DA, Tagarro I, Carmen Díez M, Sandborn WJ. Prevalence of Fistulizing Crohn's Disease in the United States: Estimate From a Systematic Literature Review Attempt and Population-Based Database Analysis. Inflamm Bowel Dis 2019;25:1773-9. [PMID: 31216573 DOI: 10.1093/ibd/izz056] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 39 |
Frei R, Fournier N, Zeitz J, Scharl M, Morell B, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L. Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn's Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort Study. J Crohns Colitis 2019;13:1292-301. [PMID: 30854548 DOI: 10.1093/ecco-jcc/jjz057] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 40 |
Schieffer KM, Kline BP, Harris LR, Deiling S, Koltun WA, Yochum GS. A differential host response to viral infection defines a subset of earlier-onset diverticulitis patients. J Gastrointestin Liver Dis 2018;27:249-55. [PMID: 30240468 DOI: 10.15403/jgld.2014.1121.273.sch] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 41 |
Bruckner RS, Nissim-Eliraz E, Marsiano N, Nir E, Shemesh H, Leutenegger M, Gottier C, Lang S, Spalinger MR, Leibl S, Rogler G, Yagel S, Scharl M, Shpigel NY. Transplantation of Human Intestine Into the Mouse: A Novel Platform for Study of Inflammatory Enterocutaneous Fistulas. J Crohns Colitis 2019;13:798-806. [PMID: 30590414 DOI: 10.1093/ecco-jcc/jjy226] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 42 |
Jones J, Aboumarzouk OM. Fistulae and Sinuses. Blandy's Urology 2019. [DOI: 10.1002/9781118863343.ch24] [Reference Citation Analysis]
|
| 43 |
Stevens TW, D'Haens GR, Duijvestein M, Bemelman WA, Buskens CJ, Gecse KB. Diagnostic accuracy of faecal calprotectin in patients with active perianal fistulas. United European Gastroenterol J 2019;7:496-506. [PMID: 31065367 DOI: 10.1177/2050640619834464] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 44 |
Böhmig M. Mechanisms of Disease, Etiology and Clinical Manifestations. Inflammatory Bowel Disease Nursing Manual 2019. [DOI: 10.1007/978-3-319-75022-4_3] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 45 |
Jain AG, FaisalUddin M, Gllava I, Gordon D, Guan J. A Rare Case of Crohn's Disease Manifesting as a Large Liver Abscess. Cureus 2018;10:e3758. [PMID: 30820378 DOI: 10.7759/cureus.3758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 46 |
Agrawal V, Nayar R, Haque MF. Transverse Colonic Stricture Along with Colo-Duodenal Fistula—a Rare and Interesting Finding in Crohn’s Disease. Indian J Surg 2018;80:527-529. [DOI: 10.1007/s12262-018-1741-4] [Reference Citation Analysis]
|
| 47 |
Leutenegger M, Bruckner R, Spalinger MR, Lang S, Rogler G, Scharl M. Eribulin Does Not Prevent Epithelial-to-Mesenchymal Transition in HT-29 Intestinal Epithelial Cells. Inflamm Intest Dis 2018;2:211-8. [PMID: 30221148 DOI: 10.1159/000490052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 48 |
Feagan BG, Schwartz D, Danese S, Rubin DT, Lissoos TW, Xu J, Lasch K. Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2. J Crohns Colitis 2018;12:621-6. [PMID: 29471381 DOI: 10.1093/ecco-jcc/jjy019] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 11.6] [Reference Citation Analysis]
|
| 49 |
Panés J, García-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la Portilla F, Goldin E, Richard MP, Diez MC, Tagarro I, Leselbaum A, Danese S; ADMIRE CD Study Group Collaborators. Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease. Gastroenterology 2018;154:1334-1342.e4. [PMID: 29277560 DOI: 10.1053/j.gastro.2017.12.020] [Cited by in Crossref: 253] [Cited by in F6Publishing: 245] [Article Influence: 50.6] [Reference Citation Analysis]
|
| 50 |
Jiang H, Shen J, Ran Z. Epithelial-mesenchymal transition in Crohn's disease. Mucosal Immunol 2018;11:294-303. [PMID: 29346350 DOI: 10.1038/mi.2017.107] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 51 |
Philandrianos C, Serrero M, Grimaud F, Magalon J, Visée C, Velier M, Francois P, Orsoni P, Magalon G, Grimaud JC, Desjeux A, Véran J, Sabatier F. First clinical case report of local microinjection of autologous fat and adipose-derived stromal vascular fraction for perianal fistula in Crohn's disease. Stem Cell Res Ther 2018;9:4. [PMID: 29321063 DOI: 10.1186/s13287-017-0736-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 52 |
Lee S, Massie I, Meran L, Li VS. Extracellular Matrix Remodeling in Intestinal Homeostasis and Disease. Intestinal Stem Cell Niche 2018. [DOI: 10.1016/bs.asn.2018.01.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 53 |
Scharl M. What Distinguishes Mechanisms of Fistula and Stricture Formation. Fibrostenotic Inflammatory Bowel Disease 2018. [DOI: 10.1007/978-3-319-90578-5_21] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 54 |
Li Y, Zhu W. Pathogenesis of Crohn's Disease–Associated Fistula and Abscess. Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications 2018. [DOI: 10.1016/b978-0-12-811388-2.00004-x] [Reference Citation Analysis]
|
| 55 |
van Haaften WT, Mortensen JH, Karsdal MA, Bay-Jensen AC, Dijkstra G, Olinga P. Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease. Aliment Pharmacol Ther 2017;46:26-39. [PMID: 28481042 DOI: 10.1111/apt.14092] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 56 |
Braithwaite GC, Lee MJ, Hind D, Brown SR. Prognostic factors affecting outcomes in fistulating perianal Crohn's disease: a systematic review. Tech Coloproctol 2017;21:501-19. [PMID: 28639073 DOI: 10.1007/s10151-017-1647-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 57 |
Sugrue J, Nordenstam J, Abcarian H, Bartholomew A, Schwartz JL, Mellgren A, Tozer PJ. Pathogenesis and persistence of cryptoglandular anal fistula: a systematic review. Tech Coloproctol 2017;21:425-32. [PMID: 28620877 DOI: 10.1007/s10151-017-1645-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 58 |
Mantarro A, Scalise P, Guidi E, Neri E. Magnetic resonance enterography in Crohn’s disease: How we do it and common imaging findings. World J Radiol 2017; 9(2): 46-54 [PMID: 28298964 DOI: 10.4329/wjr.v9.i2.46] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 59 |
Jeuring SF, van den Heuvel TR, Liu LY, Zeegers MP, Hameeteman WH, Romberg-Camps MJ, Oostenbrug LE, Masclee AA, Jonkers DM, Pierik MJ. Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort. Am J Gastroenterol 2017;112:325-36. [PMID: 27922024 DOI: 10.1038/ajg.2016.524] [Cited by in Crossref: 101] [Cited by in F6Publishing: 88] [Article Influence: 16.8] [Reference Citation Analysis]
|
| 60 |
Obrazcov IV, Shirokikh KE, Shapina MA, Sukhina MA, Khalif IL. T-CELL IMMUNE PHENOTYPING FOR DIFFERENTIAL DIAGNOSIS OF CROHN'S DISEASE ASSOCIATED ANORECTAL FISTULA: A PILOT STUDY. Koloproktologiâ 2016. [DOI: 10.33878/2073-7556-2016-0-4-32-41] [Reference Citation Analysis]
|
| 61 |
Ratto C, Litta F, Lucchetti D, Parello A, Boninsegna A, Arena V, Donisi L, Calapà F, Sgambato A. Immunopathological characterization of cryptoglandular anal fistula: a pilot study investigating its pathogenesis. Colorectal Dis 2016;18:O436-44. [PMID: 27649390 DOI: 10.1111/codi.13527] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 62 |
Segal AW. Making sense of the cause of Crohn's - a new look at an old disease. F1000Res. 2016;5:2510. [PMID: 28105308 DOI: 10.12688/f1000research.9699.2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 63 |
Segal AW. Making sense of the cause of Crohn's - a new look at an old disease. F1000Res 2016;5:2510. [PMID: 28105308 DOI: 10.12688/f1000research.9699.2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 64 |
Panés J, García-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la Portilla F, Goldin E, Richard MP, Leselbaum A, Danese S; ADMIRE CD Study Group Collaborators. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet 2016;388:1281-90. [PMID: 27477896 DOI: 10.1016/S0140-6736(16)31203-X] [Cited by in Crossref: 629] [Cited by in F6Publishing: 596] [Article Influence: 89.9] [Reference Citation Analysis]
|
| 65 |
Goffin L, Fagagnini S, Vicari A, Mamie C, Melhem H, Weder B, Lutz C, Lang S, Scharl M, Rogler G, Chvatchko Y, Hausmann M. Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis. Inflamm Bowel Dis 2016;22:2041-57. [PMID: 27542125 DOI: 10.1097/MIB.0000000000000863] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 66 |
Siegmund B, Feakins RM, Barmias G, Ludvig JC, Teixeira FV, Rogler G, Scharl M. Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease. J Crohns Colitis 2016;10:377-86. [PMID: 26681764 DOI: 10.1093/ecco-jcc/jjv228] [Cited by in Crossref: 52] [Cited by in F6Publishing: 82] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 67 |
Scharl M, Bruckner RS, Rogler G. The two sides of the coin: Similarities and differences in the pathomechanisms of fistulas and stricture formations in irritable bowel disease. United European Gastroenterol J 2016;4:506-14. [PMID: 27536360 DOI: 10.1177/2050640616635957] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 68 |
Weiss A, Sandler B. Lower extremity necrotizing fasciitis: A unique initial presentation of Crohn's disease. Ann Med Surg (Lond) 2015;4:215-6. [PMID: 26155362 DOI: 10.1016/j.amsu.2015.05.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 69 |
Marzo M, Felice C, Pugliese D, Andrisani G, Mocci G, Armuzzi A, Guidi L. Management of perianal fistulas in Crohn’s disease: An up-to-date review. World J Gastroenterol 2015; 21(5): 1394-1403 [PMID: 25663759 DOI: 10.3748/wjg.v21.i5.1394] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 66] [Article Influence: 7.4] [Reference Citation Analysis]
|
